Staphar 2gm Injection

Staphar 2gm Injection contains flucloxacillin, an antibiotic belonging to the penicillin class of drugs. It is used to treat bacterial infections caused by strains sensitive to its antimicrobial action. It is commonly prescribed for infections caused by Staphylococcus bacteria, including Staphylococcus aureus. The medication treats skin and soft tissue infections such as boils, abscesses, cellulitis, and wound infections. Cellulitis is a bacterial skin infection characterised by redness, swelling, and pain. This medication can also treat certain respiratory tract infections caused by susceptible bacteria. It is important to use it under the guidance and prescription of a qualified healthcare provider.

Individuals with a history of hypersensitivity or severe allergic reactions such as anaphylaxis to penicillins or other beta-lactam antibiotics should not take Staphar 2gm Injection. You should avoid taking this medication if you have a history of jaundice (yellowing of the skin and eyes) associated with penicillin or other beta-lactam antibiotics. It should be avoided in individuals with infectious mononucleosis (mono or glandular fever), as it may lead to a rash. It should be used cautiously in individuals with certain medical conditions such as kidney impairment or a history of gastrointestinal disease. It can be safe for children when prescribed by a healthcare provider. Elderly individuals can take Staphar 2gm Injection, but their kidney and liver function may impact the dosing.

Staphar 2gm Injection is used in the following: Skin and soft tissue infections Bone and joint infections Respiratory tract infections Endocarditis prophylaxis Staphylococcal infections.

Staphar 2gm Injection exerts its therapeutic effect through inhibition of bacterial cell wall synthesis. As a beta-lactam antibiotic, it interferes with the activity of enzymes known as penicillin-binding proteins (PBPs) that are crucial for cross-linking bacterial cell wall components. Disrupting this process weakens the integrity of the bacterial cell wall, leading to osmotic instability and, ultimately, bacterial cell death. This mechanism primarily targets bacteria like Staphylococcus aureus, rendering them susceptible to the drug's action.

Staphar 2gm Injection is swallowed orally with a whole glass of water. The frequency depends on age, weight, and severity of the condition, and is decided by a healthcare provider.

Staphar 2gm Injection causes some side effects like all medications, although not everyone will experience them. Serious Severe allergic reactions Severe skin reactions Liver dysfunction Common Gastrointestinal disturbances Skin rash Yeast infections Digestive upset Pain or inflammation at the injection site (IV formulation).

Inform your healthcare provider about any allergies, especially to penicillin antibiotics, and any previous adverse reactions to antibiotics before starting Staphar 2gm Injection. Patients with liver conditions or renal impairment need close monitoring, as the drug is metabolised in the liver and excreted through the kidneys. Complete the full prescribed course to prevent antibiotic resistance. Inform your doctor if you have underlying medical conditions, are pregnant, breastfeeding, or taking other medications. Be cautious of potential drug interactions and report any severe side effects, such as serious skin reactions or allergic responses, immediatel